<DOC>
	<DOCNO>NCT00375687</DOCNO>
	<brief_summary>The purpose study determine whether early hormonotherapy effective treatment high risk prostate cancer patient radical prostatectomy .</brief_summary>
	<brief_title>Investigation Early Hormonotherapy Efficacy Prostate Cancer</brief_title>
	<detailed_description>The primary purpose study evaluate hypothesis , early administration adjuvant hormonotherapy ( triptorelin ) prolong survival data high risk patient . Control group ( randomise study ) treat hormonotherapy , PSA recidive appear ( demand treatment ) . Secondary purpose compare PSA dinamics quality life data group .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>preoperative PSA &gt; 20ng/ml postoperative PSA &gt; 0.2 ng/ml Gleason &gt; 7 pT3b signated infomed consent neoadjuvant hormonaltherapy RP R1 RP N+ RP unstable cncomitant condition</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>Prostate cancer</keyword>
</DOC>